Brian Wells to Angiotensin-Converting Enzyme Inhibitors
This is a "connection" page, showing publications Brian Wells has written about Angiotensin-Converting Enzyme Inhibitors.
Connection Strength
0.130
-
Al-Sayed NA, Gao T, Wells BJ, Yu C, Zimmerman RS. Angiotensin-converting enzyme inhibitors reduce albuminuria more than angiotensin receptor blockers in patients with type 2 diabetes. Endocr Pract. 2013 Jul-Aug; 19(4):579-86.
Score: 0.110
-
Pantalone KM, Kattan MW, Yu C, Wells BJ, Arrigain S, Jain A, Atreja A, Zimmerman RS. The risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: a retrospective analysis. Acta Diabetol. 2009 Jun; 46(2):145-54.
Score: 0.020